CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 281 filers reported holding CYTOKINETICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $677,000 | -24.8% | 14,769 | -20.5% | 0.00% | -25.0% |
| Q3 2022 | $900,000 | +23.3% | 18,579 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $730,000 | -47.3% | 18,579 | -50.6% | 0.00% | -40.0% |
| Q1 2022 | $1,385,000 | -54.4% | 37,630 | -43.5% | 0.01% | -50.0% |
| Q4 2021 | $3,037,000 | +27.6% | 66,629 | 0.0% | 0.01% | +25.0% |
| Q3 2021 | $2,381,000 | +80.5% | 66,629 | 0.0% | 0.01% | +60.0% |
| Q2 2021 | $1,319,000 | -14.9% | 66,629 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $1,550,000 | +11.9% | 66,629 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $1,385,000 | -20.9% | 66,629 | -17.6% | 0.01% | -40.0% |
| Q3 2020 | $1,750,000 | -8.1% | 80,829 | 0.0% | 0.01% | -9.1% |
| Q2 2020 | $1,905,000 | +70.7% | 80,829 | -14.6% | 0.01% | +37.5% |
| Q1 2020 | $1,116,000 | +25.4% | 94,644 | +12.8% | 0.01% | +60.0% |
| Q4 2019 | $890,000 | +2.9% | 83,892 | +10.4% | 0.01% | 0.0% |
| Q3 2019 | $865,000 | -22.6% | 75,995 | -23.5% | 0.01% | -16.7% |
| Q2 2019 | $1,117,000 | +26.8% | 99,325 | -8.8% | 0.01% | +20.0% |
| Q1 2019 | $881,000 | +67.2% | 108,875 | +30.6% | 0.01% | +66.7% |
| Q4 2018 | $527,000 | -13.9% | 83,387 | +34.2% | 0.00% | 0.0% |
| Q3 2018 | $612,000 | +0.3% | 62,119 | -15.5% | 0.00% | 0.0% |
| Q2 2018 | $610,000 | +15.3% | 73,529 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $529,000 | -19.4% | 73,529 | -8.6% | 0.00% | 0.0% |
| Q4 2017 | $656,000 | +73.1% | 80,480 | +207.8% | 0.00% | +50.0% |
| Q3 2017 | $379,000 | -69.3% | 26,147 | -74.4% | 0.00% | -33.3% |
| Q2 2017 | $1,236,000 | +88.4% | 102,132 | +100.0% | 0.00% | -25.0% |
| Q1 2017 | $656,000 | +21.7% | 51,066 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $539,000 | +14.9% | 51,066 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $469,000 | -3.3% | 51,066 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $485,000 | +267.4% | 51,066 | +173.0% | 0.00% | +200.0% |
| Q1 2016 | $132,000 | -32.7% | 18,706 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $196,000 | +300.0% | 18,706 | +154.9% | 0.00% | – |
| Q3 2015 | $49,000 | – | 7,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |